1 Market Overview
1.1 Kidney Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Kidney Disease Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Kidney Disease Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chronic Glomerulonephritis
1.3.3 Nephrotic Syndrome
1.3.4 Chronic Renal Failure
1.3.5 Kidney Stones
1.3.6 Renal Cyst (polycystic Kidney)
1.3.7 Diabetic Nephropathy
1.3.8 Hypertensive Nephropathy
1.3.9 Purpura Nephritis
1.3.10 Lupus Nephritis
1.3.11 Pediatric Kidney Disease
1.4 Global Kidney Disease Drugs Market Size & Forecast
1.4.1 Global Kidney Disease Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Kidney Disease Drugs Sales in Volume (2017-2028)
1.4.3 Global Kidney Disease Drugs Price (2017-2028)
1.5 Global Kidney Disease Drugs Production Capacity Analysis
1.5.1 Global Kidney Disease Drugs Total Production Capacity (2017-2028)
1.5.2 Global Kidney Disease Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Kidney Disease Drugs Market Drivers
1.6.2 Kidney Disease Drugs Market Restraints
1.6.3 Kidney Disease Drugs Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Kidney Disease Drugs Product and Services
2.1.4 GlaxoSmithKline Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Kidney Disease Drugs Product and Services
2.2.4 Sanofi Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Kidney Disease Drugs Product and Services
2.3.4 Roche Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Kidney Disease Drugs Product and Services
2.4.4 Pfizer Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Kidney Disease Drugs Product and Services
2.5.4 AstraZeneca Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Keryx Biopharmaceuticals
2.6.1 Keryx Biopharmaceuticals Details
2.6.2 Keryx Biopharmaceuticals Major Business
2.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Product and Services
2.6.4 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Kissei Pharmaceutical
2.7.1 Kissei Pharmaceutical Details
2.7.2 Kissei Pharmaceutical Major Business
2.7.3 Kissei Pharmaceutical Kidney Disease Drugs Product and Services
2.7.4 Kissei Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Kidney Disease Drugs Product and Services
2.8.4 AbbVie Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Kidney Disease Drugs Product and Services
2.9.4 Amgen Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Product and Services
2.10.4 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Tianjin Tongrentang Group
2.11.1 Tianjin Tongrentang Group Details
2.11.2 Tianjin Tongrentang Group Major Business
2.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Product and Services
2.11.4 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
2.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Details
2.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Major Business
2.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product and Services
2.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Datong Liqun Pharmaceutical
2.13.1 Datong Liqun Pharmaceutical Details
2.13.2 Datong Liqun Pharmaceutical Major Business
2.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Product and Services
2.13.4 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Hebei Ruisen Pharmaceutical
2.14.1 Hebei Ruisen Pharmaceutical Details
2.14.2 Hebei Ruisen Pharmaceutical Major Business
2.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product and Services
2.14.4 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Changxing Pharmaceutical
2.15.1 Changxing Pharmaceutical Details
2.15.2 Changxing Pharmaceutical Major Business
2.15.3 Changxing Pharmaceutical Kidney Disease Drugs Product and Services
2.15.4 Changxing Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 zhejiang Shengbokang Pharmaceutical
2.16.1 zhejiang Shengbokang Pharmaceutical Details
2.16.2 zhejiang Shengbokang Pharmaceutical Major Business
2.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product and Services
2.16.4 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Kidney Disease Drugs Breakdown Data by Manufacturer
3.1 Global Kidney Disease Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Kidney Disease Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Kidney Disease Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Kidney Disease Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Kidney Disease Drugs Manufacturer Market Share in 2021
3.5 Global Kidney Disease Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Kidney Disease Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Kidney Disease Drugs Market Size by Region
4.1.1 Global Kidney Disease Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Kidney Disease Drugs Revenue by Region (2017-2028)
4.2 North America Kidney Disease Drugs Revenue (2017-2028)
4.3 Europe Kidney Disease Drugs Revenue (2017-2028)
4.4 Asia-Pacific Kidney Disease Drugs Revenue (2017-2028)
4.5 South America Kidney Disease Drugs Revenue (2017-2028)
4.6 Middle East and Africa Kidney Disease Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Kidney Disease Drugs Sales in Volume by Type (2017-2028)
5.2 Global Kidney Disease Drugs Revenue by Type (2017-2028)
5.3 Global Kidney Disease Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Kidney Disease Drugs Sales in Volume by Application (2017-2028)
6.2 Global Kidney Disease Drugs Revenue by Application (2017-2028)
6.3 Global Kidney Disease Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Kidney Disease Drugs Sales by Type (2017-2028)
7.2 North America Kidney Disease Drugs Sales by Application (2017-2028)
7.3 North America Kidney Disease Drugs Market Size by Country
7.3.1 North America Kidney Disease Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Kidney Disease Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Kidney Disease Drugs Sales by Type (2017-2028)
8.2 Europe Kidney Disease Drugs Sales by Application (2017-2028)
8.3 Europe Kidney Disease Drugs Market Size by Country
8.3.1 Europe Kidney Disease Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Kidney Disease Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Kidney Disease Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Kidney Disease Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Kidney Disease Drugs Market Size by Region
9.3.1 Asia-Pacific Kidney Disease Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Kidney Disease Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Kidney Disease Drugs Sales by Type (2017-2028)
10.2 South America Kidney Disease Drugs Sales by Application (2017-2028)
10.3 South America Kidney Disease Drugs Market Size by Country
10.3.1 South America Kidney Disease Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Kidney Disease Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Kidney Disease Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Kidney Disease Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Kidney Disease Drugs Market Size by Country
11.3.1 Middle East & Africa Kidney Disease Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Kidney Disease Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Kidney Disease Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Kidney Disease Drugs
12.3 Kidney Disease Drugs Production Process
12.4 Kidney Disease Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Kidney Disease Drugs Typical Distributors
13.3 Kidney Disease Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Kidney Disease Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Kidney Disease Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Kidney Disease Drugs Product and Services
Table 6. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Kidney Disease Drugs Product and Services
Table 10. Sanofi Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Kidney Disease Drugs Product and Services
Table 14. Roche Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Kidney Disease Drugs Product and Services
Table 18. Pfizer Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Major Business
Table 21. AstraZeneca Kidney Disease Drugs Product and Services
Table 22. AstraZeneca Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Keryx Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Keryx Biopharmaceuticals Major Business
Table 25. Keryx Biopharmaceuticals Kidney Disease Drugs Product and Services
Table 26. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Kissei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Kissei Pharmaceutical Major Business
Table 29. Kissei Pharmaceutical Kidney Disease Drugs Product and Services
Table 30. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. AbbVie Basic Information, Manufacturing Base and Competitors
Table 32. AbbVie Major Business
Table 33. AbbVie Kidney Disease Drugs Product and Services
Table 34. AbbVie Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Amgen Basic Information, Manufacturing Base and Competitors
Table 36. Amgen Major Business
Table 37. Amgen Kidney Disease Drugs Product and Services
Table 38. Amgen Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceutical Industries Major Business
Table 41. Teva Pharmaceutical Industries Kidney Disease Drugs Product and Services
Table 42. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Tianjin Tongrentang Group Basic Information, Manufacturing Base and Competitors
Table 44. Tianjin Tongrentang Group Major Business
Table 45. Tianjin Tongrentang Group Kidney Disease Drugs Product and Services
Table 46. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Major Business
Table 49. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product and Services
Table 50. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Datong Liqun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Datong Liqun Pharmaceutical Major Business
Table 53. Datong Liqun Pharmaceutical Kidney Disease Drugs Product and Services
Table 54. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Hebei Ruisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Hebei Ruisen Pharmaceutical Major Business
Table 57. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product and Services
Table 58. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Changxing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Changxing Pharmaceutical Major Business
Table 61. Changxing Pharmaceutical Kidney Disease Drugs Product and Services
Table 62. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. zhejiang Shengbokang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. zhejiang Shengbokang Pharmaceutical Major Business
Table 65. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product and Services
Table 66. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Kidney Disease Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 68. Global Kidney Disease Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Kidney Disease Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Kidney Disease Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Kidney Disease Drugs Production Site of Key Manufacturer
Table 72. Kidney Disease Drugs New Entrant and Capacity Expansion Plans
Table 73. Kidney Disease Drugs Mergers & Acquisitions in the Past Five Years
Table 74. Global Kidney Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Global Kidney Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Global Kidney Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Kidney Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Global Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Global Kidney Disease Drugs Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Kidney Disease Drugs Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Kidney Disease Drugs Price by Type (2017-2022) & (US$/Unit)
Table 83. Global Kidney Disease Drugs Price by Type (2023-2028) & (US$/Unit)
Table 84. Global Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 85. Global Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Global Kidney Disease Drugs Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Kidney Disease Drugs Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Kidney Disease Drugs Price by Application (2017-2022) & (US$/Unit)
Table 89. Global Kidney Disease Drugs Price by Application (2023-2028) & (US$/Unit)
Table 90. North America Kidney Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 91. North America Kidney Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 92. North America Kidney Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Kidney Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 95. North America Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 96. North America Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 97. North America Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Europe Kidney Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 99. Europe Kidney Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 100. Europe Kidney Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Kidney Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Europe Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Europe Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Europe Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Asia-Pacific Kidney Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 107. Asia-Pacific Kidney Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 108. Asia-Pacific Kidney Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Kidney Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 111. Asia-Pacific Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 112. Asia-Pacific Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 113. Asia-Pacific Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 114. South America Kidney Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 115. South America Kidney Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 116. South America Kidney Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Kidney Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 119. South America Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 120. South America Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 121. South America Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Middle East & Africa Kidney Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 123. Middle East & Africa Kidney Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 124. Middle East & Africa Kidney Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Kidney Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 127. Middle East & Africa Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 128. Middle East & Africa Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 129. Middle East & Africa Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 130. Kidney Disease Drugs Raw Material
Table 131. Key Manufacturers of Kidney Disease Drugs Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Kidney Disease Drugs Typical Distributors
Table 135. Kidney Disease Drugs Typical Customers
List of Figures
Figure 1. Kidney Disease Drugs Picture
Figure 2. Global Kidney Disease Drugs Revenue Market Share by Type in 2021
Figure 3. Tablets
Figure 4. Capsule
Figure 5. Other
Figure 6. Global Kidney Disease Drugs Revenue Market Share by Application in 2021
Figure 7. Chronic Glomerulonephritis
Figure 8. Nephrotic Syndrome
Figure 9. Chronic Renal Failure
Figure 10. Kidney Stones
Figure 11. Renal Cyst (polycystic Kidney)
Figure 12. Diabetic Nephropathy
Figure 13. Hypertensive Nephropathy
Figure 14. Purpura Nephritis
Figure 15. Lupus Nephritis
Figure 16. Global Kidney Disease Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 17. Global Kidney Disease Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Kidney Disease Drugs Sales (2017-2028) & (K Units)
Figure 19. Global Kidney Disease Drugs Price (2017-2028) & (US$/Unit)
Figure 20. Global Kidney Disease Drugs Production Capacity (2017-2028) & (K Units)
Figure 21. Global Kidney Disease Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Kidney Disease Drugs Market Drivers
Figure 23. Kidney Disease Drugs Market Restraints
Figure 24. Kidney Disease Drugs Market Trends
Figure 25. Global Kidney Disease Drugs Sales Market Share by Manufacturer in 2021
Figure 26. Global Kidney Disease Drugs Revenue Market Share by Manufacturer in 2021
Figure 27. Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Kidney Disease Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Kidney Disease Drugs Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Kidney Disease Drugs Sales Market Share by Region (2017-2028)
Figure 31. Global Kidney Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 32. North America Kidney Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Europe Kidney Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Kidney Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 35. South America Kidney Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Kidney Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 37. Global Kidney Disease Drugs Sales Market Share by Type (2017-2028)
Figure 38. Global Kidney Disease Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Global Kidney Disease Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 40. Global Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 41. Global Kidney Disease Drugs Revenue Market Share by Application (2017-2028)
Figure 42. Global Kidney Disease Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 43. North America Kidney Disease Drugs Sales Market Share by Type (2017-2028)
Figure 44. North America Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 45. North America Kidney Disease Drugs Sales Market Share by Country (2017-2028)
Figure 46. North America Kidney Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 47. United States Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Kidney Disease Drugs Sales Market Share by Type (2017-2028)
Figure 51. Europe Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Kidney Disease Drugs Sales Market Share by Country (2017-2028)
Figure 53. Europe Kidney Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 54. Germany Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Kidney Disease Drugs Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Kidney Disease Drugs Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Kidney Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 63. China Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Kidney Disease Drugs Sales Market Share by Type (2017-2028)
Figure 70. South America Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 71. South America Kidney Disease Drugs Sales Market Share by Country (2017-2028)
Figure 72. South America Kidney Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Kidney Disease Drugs Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Kidney Disease Drugs Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Kidney Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Kidney Disease Drugs in 2021
Figure 84. Manufacturing Process Analysis of Kidney Disease Drugs
Figure 85. Kidney Disease Drugs Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer